TABLE 1:
Seroprevalence for 10 selected pathogens in European wild boar from Greece
| Seropositivity (%; 95% CI) |
|||||
|---|---|---|---|---|---|
| Pathogen | Serological assay | Overall (n=94) | Mountain range A Rodopi (n=43) | Mountain range B CENTAL (n=28) | Mountain range C Pindos (n=23) |
| Porcine circovirus type 2 (PCV-2) | ELISA (Ingenasa) | 18/94 (19.1%; 11.15 to 27.05) | 5/43 (11.6%; 2.03 to 21.17) | 9/28 (32.1%; 14.81 to 49.39) | 4/23 (17.4%; 1.91 to 32.89) |
| Porcine reproductive and respiratory syndrome virus (PRRSV) | ELISA (IDEXX laboratories) | 12/94 (12.8%; 6.05 to 19.55) | 3/43 (7%; −0.63 to 14.63) | 9/28 (32.1%; 14.81 to 49.39) | 0/23 (0%) |
| Aujeszky's disease virus (ADV) | ELISA (IDEXX Laboratories) | 33/94 (35.1%; 25.45 to 44.75) | 16/43 (37.2%; 22.75 to 51.65) | 14/28 (50%; 31.48 to 68.52) | 3/23 (13%; −0.74 to 26.74) |
| Influenza A (IA) virus | ELISA (Ingenasa) | 1/94 (1.1%; −1.01 to 3.21) | 1/43 (2.3%; −2.18 to 6.78) | 0/28 (0%) | 0/23 (0%) |
| Actinobacillus pleuropneumoniae | ELISA (IDEXX Laboratories) | 54/94 (57.4%; 47.4 to 67.4) | 22/43 (51.2%; 36.26 to 66.14) | 18/28 (64.3%; 46.55 to 82.05) | 14/23 (60.9%; 40.96 to 80.84) |
| Mycoplasma hyopneumoniae | ELISA (IDEXX Laboratories) | 0/94 (0%) | 0/43 (0%) | 0/28 (0%) | 0/23 (0%) |
| Salmonella species | ELISA (IDEXX Laboratories) | 4/94 (4.3%; 0.2 to 8.4) | 1/43 (2.3%; −2.18 to 6.78) | 1/28 (3.6%; −3.3 to 10.5) | 2/23 (8.7%; −2.82 to 20.22) |
| Trichinella species | ELISA (Institut Pourquier) | 6/94 (6.4%; 1.45 to 11.35) | 2/43 (4.6%; −1.66 to 10.86) | 1/28 (3.6%; −3.3 to 10.5) | 3/23 (13%; −0.74 to 26.74) |
| Toxoplasma gondii | Indirect fluorescent antibody test (Fuller Laboratories) | 5/94 (5.2%; 0.71 to 9.69) | 4/43 (9.3%; 0.62 to 17.98) | 0/23 (0%) | 1/23 (4.3%; −3.99 to 12.59) |
| Neospora caninum | Indirect fluorescent antibody test (Fuller Laboratories) | 1/94 (1.1%; 1.01 to 3.21) | 0/43 (0%) | 1/28 (3.6%; −3.3 to 10.5) | 0/23 (0%) |